E. Pungolino

Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group.

L. Pagano, M. Montillo, R. Stasi, 1993, Leukemia.

Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission.

V. Vitale, R. Corvò, A. Bacigalupo, 1991, Leukemia & lymphoma.

Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H

B. Brando, V. Rossi, R. Cairoli, 2004, Leukemia.

Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients.

M. Gobbi, G. Gaidano, C. Gambacorti-Passerini, 2015, Leukemia research.

Autologous and allogeneic bone marrow transplantation in acute myeloid leukemia in first complete remission: an update of the Genoa experience with 159 patients

V. Vitale, R. Corvò, A. Gallamini, 1992, Annals of Hematology.

Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.

M. Federico, E. Prencipe, F. Frassoni, 1996, Leukemia & lymphoma.